Loubeyrat, France

Norbert Busch


Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 94(Granted Patents)


Location History:

  • Loubeyrat, FR (1976 - 1977)
  • La Tourette, FR (1977 - 1978)
  • Manzat, FR (1977 - 1985)

Company Filing History:


Years Active: 1976-1985

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Norbert Busch: Innovator in Pharmaceutical Compounds

Introduction

Norbert Busch is a notable inventor based in Loubeyrat, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic properties. With a total of 10 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

One of his latest inventions involves benzoxazolinones, which are compounds that exhibit CNS activity and particularly hypnotic properties. These compounds can be utilized in the treatment of heart failure, showcasing their potential in addressing critical health issues. Another significant patent is for 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl-4-dibenzofuranone, which possesses potent anti-bronchoconstrictor properties. This invention highlights his focus on creating effective pharmaceutical solutions.

Career Highlights

Throughout his career, Norbert Busch has worked with esteemed organizations such as the Centre Européen de Recherches Mauvernay. His dedication to research and innovation has led to the development of valuable compounds that contribute to advancements in medicine.

Collaborations

Norbert has collaborated with notable individuals in his field, including Jacques Moleyre and Andre J Monteil. These partnerships have fostered an environment of innovation and have been instrumental in his research endeavors.

Conclusion

Norbert Busch's contributions to pharmaceutical inventions demonstrate his commitment to improving health outcomes through innovative compounds. His work continues to influence the medical field and inspire future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…